Journal of Controlled Release(accepted for publication)
Development of a long acting FGF21 analogue-albumin fusion protein and its anti-diabetic effects
Hiroshi Watanabe, Masako Miyahisa, Mayuko Chikamatsu, Kento Nishida, Yuki Minayoshi, Mei Takano, Shota Ichimizu, Yoshihiro Kobashigawa, Hiroshi Morioka, Hitoshi Maeda and Toru Maruyama